SBRA Quote, Financials, Valuation and Earnings

Gladstone Commercial Corp. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of 9.88%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat Gladstone Commercial Corp.'s return on equity of 5.96%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.00, signalling upside risk potential of 7.14%. On the other hand Gladstone Commercial Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 7.95%. Given that Gladstone Commercial Corp. has higher upside potential than Sabra Health Care REIT, Inc., analysts believe Gladstone Commercial Corp. is more attractive than Sabra Health Care REIT, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.668, which suggesting that the stock is 33.202% less volatile than S&P 500. In comparison Gladstone Commercial Corp. has a beta of 1.116, suggesting its more volatile than the S&P 500 by 11.642%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.12%. Gladstone Commercial Corp. offers a yield of 10.36% to investors and pays a quarterly dividend of $0.10 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. Gladstone Commercial Corp. pays out 453.52% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are larger than Gladstone Commercial Corp. quarterly revenues of $40.8M. Sabra Health Care REIT, Inc.'s net income of $22.5M is higher than Gladstone Commercial Corp.'s net income of $4M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.96x while Gladstone Commercial Corp.'s PE ratio is 62.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.31x versus 3.41x for Gladstone Commercial Corp.. Usually stocks with elevated PS ratios are considered overvalued.

LTC Properties, Inc. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of -26.43%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat LTC Properties, Inc.'s return on equity of 3.74%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.00, signalling upside risk potential of 7.14%. On the other hand LTC Properties, Inc. has an analysts' consensus of $38.14 which suggests that it could fall by -3.22%. Given that Sabra Health Care REIT, Inc. has higher upside potential than LTC Properties, Inc., analysts believe Sabra Health Care REIT, Inc. is more attractive than LTC Properties, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.668, which suggesting that the stock is 33.202% less volatile than S&P 500. In comparison LTC Properties, Inc. has a beta of 0.619, suggesting its less volatile than the S&P 500 by 38.095%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.12%. LTC Properties, Inc. offers a yield of 5.79% to investors and pays a quarterly dividend of $0.19 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. LTC Properties, Inc. pays out 111.63% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are larger than LTC Properties, Inc. quarterly revenues of $70.7M. Sabra Health Care REIT, Inc.'s net income of $22.5M is higher than LTC Properties, Inc.'s net income of -$18.7M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.96x while LTC Properties, Inc.'s PE ratio is 53.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.31x versus 7.74x for LTC Properties, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UMH Properties, Inc. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of 13.88%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat UMH Properties, Inc.'s return on equity of 2.93%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.00, signalling upside risk potential of 7.14%. On the other hand UMH Properties, Inc. has an analysts' consensus of $19.07 which suggests that it could grow by 18.24%. Given that UMH Properties, Inc. has higher upside potential than Sabra Health Care REIT, Inc., analysts believe UMH Properties, Inc. is more attractive than Sabra Health Care REIT, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.668, which suggesting that the stock is 33.202% less volatile than S&P 500. In comparison UMH Properties, Inc. has a beta of 1.087, suggesting its more volatile than the S&P 500 by 8.733%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.12%. UMH Properties, Inc. offers a yield of 5.52% to investors and pays a quarterly dividend of $0.23 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. UMH Properties, Inc. pays out 2575.76% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are larger than UMH Properties, Inc. quarterly revenues of $66.9M. Sabra Health Care REIT, Inc.'s net income of $22.5M is higher than UMH Properties, Inc.'s net income of $9.3M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.96x while UMH Properties, Inc.'s PE ratio is 211.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.31x versus 5.26x for UMH Properties, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Ventas, Inc. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of 4.66%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat Ventas, Inc.'s return on equity of 2.16%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.00, signalling upside risk potential of 7.14%. On the other hand Ventas, Inc. has an analysts' consensus of $88.70 which suggests that it could grow by 3.51%. Given that Sabra Health Care REIT, Inc. has higher upside potential than Ventas, Inc., analysts believe Sabra Health Care REIT, Inc. is more attractive than Ventas, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.668, which suggesting that the stock is 33.202% less volatile than S&P 500. In comparison Ventas, Inc. has a beta of 0.769, suggesting its less volatile than the S&P 500 by 23.07%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.12%. Ventas, Inc. offers a yield of 2.24% to investors and pays a quarterly dividend of $0.48 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. Ventas, Inc. pays out 353.33% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are smaller than Ventas, Inc. quarterly revenues of $1.6B. Sabra Health Care REIT, Inc.'s net income of $22.5M is lower than Ventas, Inc.'s net income of $73M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.96x while Ventas, Inc.'s PE ratio is 158.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.31x versus 6.79x for Ventas, Inc.. Usually stocks with elevated PS ratios are considered overvalued.